• Investor Centre
    • Live Investor Briefing
    • Share Price and Announcements
    • Corporate Governance
  • About Us
  • News & media
    • Webcast Replays
      • Wellnex Life Q&A update with Zack Bozinovski
      • Unlocking the over-the-counter medicinal cannabis opportunity
  • Contact
  • Investor Centre
    • Live Investor Briefing
    • Share Price and Announcements
    • Corporate Governance
  • About Us
  • News & media
    • Webcast Replays
      • Wellnex Life Q&A update with Zack Bozinovski
      • Unlocking the over-the-counter medicinal cannabis opportunity
  • Contact
Happy family: mother, father, children son and  daughter on nature  on sunset

Company news: Emyria; Wellnex Life; Neurotech International; Melodiol Global Health

Emyria has announced a number of changes to its board as the ASX-listed firm looks...

36412-wnx-1280x720-800x430

Financial results: Avecho; Wellnex; Zelira; Emyria; Botanix; MGC Pharma; AusCann; Epsilon; Melodiol; Bioxyne

Avecho Biotechnology saw revenue from ordinary activities fall 41% to A$446k in the half year...

36412-wnx-1280x720-800x430

Wellnex Life snaps up topical pain relief brand to complement medicinal cannabis strategy

ASX-listed Wellnex Life has entered into a binding agreement to acquire topical pain relief brand...

George-pic

Company news: Wellnex Life; Creso Pharma; MGC Pharma; Zelira Therapeutics

Wellnex Life has added Chemist Warehouse to its joint venture with OneLife Botanicals as it...

Releaf-Group-1

Company news: Releaf Group; Bod; Wellnex Life; MGC Pharma; MediCann Health

Cannabis franchise Releaf Group has opened expressions of interest (EOI) to acquire its New Zealand...

Releaf-Group-1

Company news: Releaf Group; Wellnex Life; MGC Pharma; MediCann Health

Cannabis franchise Releaf Group has opened expressions of interest (EOI) to acquire its New Zealand...

chemist-scaled

Wellnex warns of ‘limited shelf space’ as firm lays groundwork for OTC launch

Wellnex Life has spoken of the opportunities of the over-the-counter CBD market but warned there...

man running

Company news: Bod Australia; Cann Group; MediCann Health; MGC Pharma; Wellnex Life

Bod Australia has successfully raised A$2 million from new and existing shareholders to fund the acquisition...

RECENT POSTS
  • Wellnex Life reports record $3m in monthly sales as it pursues dual listing on LSE
  • Wellnex Life (ASX:WNX) Investor Briefing – 19th December 2024
  • Wellnex ready for dual UK listing in new year after record November sales
  • ASX wellness stocks offering calm and anxiety relief – Part 2
  • Wellnex Life (ASX:WNX) Q&A – 9th February 2024
SHARE THIS POST
  • FB
  • Insta
  • Group 23
Home
About us
Contact us
Privacy Policy




*proposed new name change for Wattle Health Australia Limited (subject to shareholder approval)

This investor centre was built by Reach Markets

©2022 Reach Markets

×

Do you qualify as a Wholesale (708) investor?

Wholesale 708 Sophisticated Investors are individuals or entities who generally qualify under Sections 708(8) and s761G(7) of the Corporations Act based on the gross income and/or net assets test verified by a qualified accountant.
  • A gross income of $250,000 or more per annum in each of the previous two financial years; or
  • Net assets of at least $2.5 million; and
  • A verified Qualified Accountant’s certificate given no more than two (2) years ago confirming the Sophisticated Investor status. Please refer to the Corporations Act: Specifically Section 708(08) and Section s761G(7)